838 related articles for article (PubMed ID: 18768435)
1. Matched unrelated or matched sibling donors result in comparable survival after allogeneic stem-cell transplantation in elderly patients with acute myeloid leukemia: a report from the cooperative German Transplant Study Group.
Schetelig J; Bornhäuser M; Schmid C; Hertenstein B; Schwerdtfeger R; Martin H; Stelljes M; Hegenbart U; Schäfer-Eckart K; Füssel M; Wiedemann B; Thiede C; Kienast J; Baurmann H; Ganser A; Kolb HJ; Ehninger G
J Clin Oncol; 2008 Nov; 26(32):5183-91. PubMed ID: 18768435
[TBL] [Abstract][Full Text] [Related]
2. Equivalent survival for sibling and unrelated donor allogeneic stem cell transplantation for acute myelogenous leukemia.
Moore J; Nivison-Smith I; Goh K; Ma D; Bradstock K; Szer J; Durrant S; Schwarer A; Bardy P; Herrmann R; Dodds A
Biol Blood Marrow Transplant; 2007 May; 13(5):601-7. PubMed ID: 17448920
[TBL] [Abstract][Full Text] [Related]
3. Comparable long-term survival after unrelated and HLA-matched sibling donor hematopoietic stem cell transplantations for acute leukemia in children younger than 18 months.
Eapen M; Rubinstein P; Zhang MJ; Camitta BM; Stevens C; Cairo MS; Davies SM; Doyle JJ; Kurtzberg J; Pulsipher MA; Ortega JJ; Scaradavou A; Horowitz MM; Wagner JE
J Clin Oncol; 2006 Jan; 24(1):145-51. PubMed ID: 16382124
[TBL] [Abstract][Full Text] [Related]
4. Prospective evaluation of allogeneic hematopoietic stem-cell transplantation from matched related and matched unrelated donors in younger adults with high-risk acute myeloid leukemia: German-Austrian trial AMLHD98A.
Schlenk RF; Döhner K; Mack S; Stoppel M; Király F; Götze K; Hartmann F; Horst HA; Koller E; Petzer A; Grimminger W; Kobbe G; Glasmacher A; Salwender H; Kirchen H; Haase D; Kremers S; Matzdorff A; Benner A; Döhner H
J Clin Oncol; 2010 Oct; 28(30):4642-8. PubMed ID: 20805454
[TBL] [Abstract][Full Text] [Related]
5. Long-term follow-up of allogeneic hematopoietic stem cell transplantation for de novo acute myelogenous leukemia with a conditioning regimen of total body irradiation and granulocyte colony-stimulating factor-combined high-dose cytarabine.
Mori T; Aisa Y; Watanabe R; Yamazaki R; Kato J; Shimizu T; Shigematsu N; Kubo A; Yajima T; Hibi T; Ikeda Y; Okamoto S
Biol Blood Marrow Transplant; 2008 Jun; 14(6):651-7. PubMed ID: 18489990
[TBL] [Abstract][Full Text] [Related]
6. Allogeneic marrow stem-cell transplantation from human leukocyte antigen-identical siblings versus human leukocyte antigen-allelic-matched unrelated donors (10/10) in patients with standard-risk hematologic malignancy: a prospective study from the French Society of Bone Marrow Transplantation and Cell Therapy.
Yakoub-Agha I; Mesnil F; Kuentz M; Boiron JM; Ifrah N; Milpied N; Chehata S; Esperou H; Vernant JP; Michallet M; Buzyn A; Gratecos N; Cahn JY; Bourhis JH; Chir Z; Raffoux C; Socié G; Golmard JL; Jouet JP;
J Clin Oncol; 2006 Dec; 24(36):5695-702. PubMed ID: 17116940
[TBL] [Abstract][Full Text] [Related]
7. High EVI1 expression predicts outcome in younger adult patients with acute myeloid leukemia and is associated with distinct cytogenetic abnormalities.
Gröschel S; Lugthart S; Schlenk RF; Valk PJ; Eiwen K; Goudswaard C; van Putten WJ; Kayser S; Verdonck LF; Lübbert M; Ossenkoppele GJ; Germing U; Schmidt-Wolf I; Schlegelberger B; Krauter J; Ganser A; Döhner H; Löwenberg B; Döhner K; Delwel R
J Clin Oncol; 2010 Apr; 28(12):2101-7. PubMed ID: 20308656
[TBL] [Abstract][Full Text] [Related]
8. Stem-cell transplantation in children with acute lymphoblastic leukemia: A prospective international multicenter trial comparing sibling donors with matched unrelated donors-The ALL-SCT-BFM-2003 trial.
Peters C; Schrappe M; von Stackelberg A; Schrauder A; Bader P; Ebell W; Lang P; Sykora KW; Schrum J; Kremens B; Ehlert K; Albert MH; Meisel R; Matthes-Martin S; Gungor T; Holter W; Strahm B; Gruhn B; Schulz A; Woessmann W; Poetschger U; Zimmermann M; Klingebiel T
J Clin Oncol; 2015 Apr; 33(11):1265-74. PubMed ID: 25753432
[TBL] [Abstract][Full Text] [Related]
9. Successful prevention of acute graft-versus-host disease using low-dose antithymocyte globulin after mismatched, unrelated, hematopoietic stem cell transplantation for acute myelogenous leukemia.
Kim HJ; Min WS; Cho BS; Eom KS; Kim YJ; Min CK; Lee S; Cho SG; Jin JY; Lee JW; Kim CC
Biol Blood Marrow Transplant; 2009 Jun; 15(6):704-17. PubMed ID: 19450755
[TBL] [Abstract][Full Text] [Related]
10. HLA Association with hematopoietic stem cell transplantation outcome: the number of mismatches at HLA-A, -B, -C, -DRB1, or -DQB1 is strongly associated with overall survival.
Loiseau P; Busson M; Balere ML; Dormoy A; Bignon JD; Gagne K; Gebuhrer L; Dubois V; Jollet I; Bois M; Perrier P; Masson D; Moine A; Absi L; Reviron D; Lepage V; Tamouza R; Toubert A; Marry E; Chir Z; Jouet JP; Blaise D; Charron D; Raffoux C
Biol Blood Marrow Transplant; 2007 Aug; 13(8):965-74. PubMed ID: 17640601
[TBL] [Abstract][Full Text] [Related]
11. Allogeneic hematopoietic cell transplantation from alternative donors in children with myelodysplastic syndrome: is that an alternative?
Kalwak K; Wójcik D; Gorczyńska E; Toporski J; Turkiewicz D; Slociak M; Ussowicz M; Pajdosz K; Socha P; Chybicka A
Transplant Proc; 2004 Jun; 36(5):1574-7. PubMed ID: 15251388
[TBL] [Abstract][Full Text] [Related]
12. Allogeneic transplantation from HLA-matched sibling or partially HLA-mismatched related donors for primary refractory acute leukemia.
Singhal S; Powles R; Henslee-Downey PJ; Chiang KY; Treleaven J; Godder K; Kulkarni S; van Rhee F; Sirohi B; Pinkerton CR; Meller S; Mehta J
Bone Marrow Transplant; 2002 Feb; 29(4):291-5. PubMed ID: 11896425
[TBL] [Abstract][Full Text] [Related]
13. Pediatric standard-risk AML with fully matched sibling donors: to transplant in first CR or not?
Gassas A; Afzal S; Ishaqi MK; Finkelstein-Shechter T; Rojas M; Dupuis A; Sung L; Doyle J
Bone Marrow Transplant; 2008 Sep; 42(6):393-6. PubMed ID: 18587434
[TBL] [Abstract][Full Text] [Related]
14. Effect of allogeneic hematopoietic stem cell transplantation from matched siblings or unrelated donors during the first complete remission in patients with cytogenetically normal acute myeloid leukemia.
Hsieh YY; Hong YC; Hsiao LT; Yu YB; Liu JH; Gau JP; Lin HN; Hsu YN; Chiou TJ; Chen PM; Tzeng CH; Liu CY
Eur J Haematol; 2011 Mar; 86(3):237-45. PubMed ID: 21155895
[TBL] [Abstract][Full Text] [Related]
15. Are matched unrelated donor transplants justified for AML in CR1?
Anasetti C; Perkins J; Nieder ML; Field T
Best Pract Res Clin Haematol; 2006; 19(2):321-8. PubMed ID: 16516129
[TBL] [Abstract][Full Text] [Related]
16. Immunogenetic factors in donors and patients that affect the outcome of hematopoietic stem cell transplantation.
Madrigal A; Shaw BE
Blood Cells Mol Dis; 2008; 40(1):40-3. PubMed ID: 17964196
[TBL] [Abstract][Full Text] [Related]
17. Second transplant for acute and chronic leukemia relapsing after first HLA-identical sibling transplant.
Eapen M; Giralt SA; Horowitz MM; Klein JP; Wagner JE; Zhang MJ; Tallman MS; Marks DI; Camitta BM; Champlin RE; Ringdén O; Bredeson CN; Martino R; Gale RP; Cairo MS; Litzow MR; deLima M
Bone Marrow Transplant; 2004 Oct; 34(8):721-7. PubMed ID: 15322568
[TBL] [Abstract][Full Text] [Related]
18. Impact of disease burden at time of allogeneic stem cell transplantation in adults with acute myeloid leukemia and myelodysplastic syndromes.
Kebriaei P; Kline J; Stock W; Kasza K; Le Beau MM; Larson RA; van Besien K
Bone Marrow Transplant; 2005 May; 35(10):965-70. PubMed ID: 15806131
[TBL] [Abstract][Full Text] [Related]
19. Donor age and degree of HLA matching have a major impact on the outcome of unrelated donor haematopoietic cell transplantation for chronic myeloid leukaemia.
Carreras E; Jiménez M; Gómez-García V; de la Cámara R; Martín C; Martínez F; Iriondo A; Sanz G; Cañizo C; Cabrera R; Sierra J; Vallejo C; López J; Martínez C; Rovira M; Fernández-Rañada JM; Torres A
Bone Marrow Transplant; 2006 Jan; 37(1):33-40. PubMed ID: 16247421
[TBL] [Abstract][Full Text] [Related]
20. The outcome of sibling and unrelated donor allogeneic stem cell transplantation in adult patients with acute myeloid leukemia in first remission who were initially refractory to first induction chemotherapy.
Cook G; Clark RE; Crawley C; Mackinnon S; Russell N; Thomson K; Pearce RM; Towlson K; Marks DI
Biol Blood Marrow Transplant; 2006 Mar; 12(3):293-300. PubMed ID: 16503498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
